Novel therapeutic strategies for adult obese asthmatics

Angela L. Linderholm, Jennifer M. Bratt, Gertrud U. Schuster, Amir Zeki, Nicholas Kenyon

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Asthma is a complex syndrome that affects an estimated 26 million people in the United States but gaps exist in the recognition and management of asthmatic subgroups. This article proposes alternative approaches for future treatments of adult obese asthmatics who do not respond to standard controller therapies, drawing parallels between seemingly disparate therapeutics through their common signaling pathways. How metformin and statins can potentially improve airway inflammation is described and supplements are suggested. A move toward more targeted therapies for asthma subgroups is needed. These therapies address asthma and the comorbidities that accompany obesity and metabolic syndrome to provide the greatest therapeutic potential.

Original languageEnglish (US)
Pages (from-to)809-823
Number of pages15
JournalImmunology and Allergy Clinics of North America
Issue number4
StatePublished - 2014


  • L-Arginine
  • Metformin
  • Nitric oxide
  • Obesity
  • Severe asthma
  • Statins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Novel therapeutic strategies for adult obese asthmatics'. Together they form a unique fingerprint.

Cite this